← Open Payments lookup

CECILIA WANG: Open Payments

NPI 1083780753 · WAYNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,265 in 83 payments from 13 companies in 2025. Trend: 2023 $859 · 2024 $1,067 · 2025 $1,265

Food & beverage: $1,155Education: $109
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.18$257
Teva Pharmaceuticals USA, Inc.11$232
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$179
ABBVIE INC.16$176
E.R. Squibb & Sons, L.L.C.5$81
Vanda Pharmaceuticals Inc.5$79
Alkermes, Inc.4$72
Validus Pharmaceuticals LLC3$51
Takeda Pharmaceuticals U.S.A., Inc.3$45
Neos Therapeutics, LP2$39

Products named: REXULTI, CAPLYTA, VRAYLAR, AUSTEDO XR, COBENFY, ARISTADA, HETLIOZ, TRINTELLIX.

Industry payments across NJ — which companies pay providers there.